At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 498 enrolled
Drug / intervention
ACYC +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2-Arm, Parallel Group Comparison Study Comparing the Efficacy and Safety of ACYC and ACYC Vehicle Gel in the Treatment of Acne Vulgaris
In Brief
A Phase 3 clinical trial evaluating ACYC and ACYC vehicle for Acne. Completed, enrolled 498 participants across 24 sites.
Detailed Summary
The primary objective of this study is to compare the efficacy and safety and tolerability of ACYC Gel and vehicle in the treatment of subjects with Acne Vulgaris.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne
CountriesUnited States
CollaboratorsDow Pharmaceutical Sciences
Timeline
Phase 3CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2012
First PostedOct 2012
Primary CompletionMay 2013
Study CompletionJul 2013
TodayJul 2026
First PostedOct 4, 2012
Enrollment StartOct 1, 2012
Primary CompletionMay 1, 2013
Study CompletionJul 1, 2013
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 13.7 years ago
Interventions
ACYCdrug
ACYC active, topically applied to the face for 12 weeks
ACYC vehicledrug
ACYC vehicle (placebo), topically applied to the face for 12 weeks